A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Journal: Science

Published: 2020-06-12

DOI: 10.1126/science.abc2241

Affiliations: 13

Authors: 25

Go to article
Institutions Share
CAS Key Laboratory of Pathogenic Microbiology and Immunology, IM CAS, China 0.39
Shenzhen Key Laboratory of Infection and Immunity at Shenzhen Third People's Hospital, SUSTech, China 0.15
Laboratory of Protein Engineering and Vaccines, TIB CAS, China 0.09
NHC Key Laboratory of Biosafety, China CDC, China 0.08
School of Basic Medical Sciences, Capital Medical University, China 0.06
Center for Influenza Research and Early-Warning (CASCIRE), IM CAS, China 0.04
Laboratory Animal Center, China CDC, China 0.04
Institute for Laboratory Animal Resources, NIFDC, China 0.04
Research Network of Immunity and Health (RNIH), BIOLS CAS, China 0.02
School of Life Sciences, USTC, China 0.02
College of Veterinary Medicine (CVM), CAU, China 0.02
Shanxi Academy of Advanced Research and Innovation (SAARI), China 0.02
University of Chinese Academy of Sciences (UCAS), China 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER